Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection

Patients with end stage kidney disease receiving in-center hemodialysis (ICHD) have had high rates of SARS-CoV-2 infection. Following infection, patients receiving ICHD frequently develop circulating antibodies to SARS-CoV-2, even with asymptomatic infection. Here, we investigated the durability and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kidney Int
Hlavní autoři: Clarke, Candice L., Prendecki, Maria, Dhutia, Amrita, Gan, Jaslyn, Edwards, Claire, Prout, Virginia, Lightstone, Liz, Parker, Eleanor, Marchesin, Federica, Griffith, Megan, Charif, Rawya, Pickard, Graham, Cox, Alison, McClure, Myra, Tedder, Richard, Randell, Paul, Greathead, Louise, Guckian, Mary, McAdoo, Stephen P., Kelleher, Peter, Willicombe, Michelle
Médium: Artigo
Jazyk:Inglês
Vydáno: International Society of Nephrology. Published by Elsevier Inc. 2021
Témata:
Clinical Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992297/
https://ncbi.nlm.nih.gov/pubmed/33774082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2021.03.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky